Predictors of active injection drug use in a cohort of patients infected with hepatitis C virus

American Journal of Public Health

Volumn 103, Issue 1, 2013, Pages 105-111

  Reed, Carrie ^a   Bliss, Caleb ^a   Stuver, Sherri O ^a   Heeren, Timothy ^a   Tumilty, Sheila ^b   Robert Jr Horsburgh, C ^a   Samet, Jeffrey H ^b   Cotton, Deborah J ^b  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOLISM; ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; RISK FACTOR; SMOKING; SUBSTANCE ABUSE; UNEMPLOYMENT;

ADULT; ALCOHOLISM; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; SMOKING; SUBSTANCE ABUSE, INTRAVENOUS; UNEMPLOYMENT; YOUNG ADULT;

EID: 84872511683     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2012.300819     Document Type: Article

References (43)

1. Global Burden of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol. 2004;44(1):20-29.
2. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144 (10):705-714. (Pubitemid 46780630)
3. Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156(4):271-278.
4. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13(17):2436-2441. (Pubitemid 46929498)
5. Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis-United States, 2007. MMWR Surveill Summ. 2009;58(3):1-27.
6. Bini EJ, Currie SL, Shen H, et al. National multicenter study of HIV testing and HIV seropositivity in patients with chronic hepatitis C virus infection. J Clin Gastroenterol. 2006;40(8):732-739. (Pubitemid 44350597)
7. Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002;34(6):831-837. (Pubitemid 34194855)
8. Murrill CS, Weeks H, Castrucci BC, et al. Agespecific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health. 2002;92(3):385-387. (Pubitemid 34184825)
9. Broers B, Helbling B, Francois A, et al. Barriers to interferon-alpha therapy are higher in intravenous drug users than in other patients with acute hepatitis C. J Hepatol. 2005;42(3):323-328. (Pubitemid 40254245)
10. Edlin BR, Kresina TF, Raymond DB, et al. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis. 2005;40 (Suppl 5):S276-S285. (Pubitemid 40490212)
11. Fleming CA, Tumilty S, Murray JE, Nunes D. Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: need for team care. Clin Infect Dis. 2005;40(suppl 5):S349-S354. (Pubitemid 40490224)
12. Dalgard O, Bjoro K, Hellum K, et al. Treatment of chronic hepatitis C in injecting drug users: 5 years" followup. Eur Addict Res. 2002;8(1):45-49. (Pubitemid 34701984)
13. Darke S, Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug Alcohol Depend. 1997;48(2):135-141. (Pubitemid 27466474)
14. Rodríguez-Llera MC, Domingo-Salvany A, Brugal MT, Silva TC, Sanchez-Niubo A, Torrens M. Psychiatric comorbidity in young heroin users. Drug Alcohol Depend. 2006;84(1):48-55. (Pubitemid 44164315)
15. Galai N, Safaeian M, Vlahov D, Bolotin A, Celentano DD. Longitudinal patterns of drug injection behavior in the ALIVE Study cohort, 1988-2000: description and determinants. Am J Epidemiol. 2003;158(7):695-704. (Pubitemid 37175518)
16. van Ameijden EJ, van den Hoek JA, Hartgers C, Coutinho RA. Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. Am J Epidemiol. 1994;139(12):1153- 1163. (Pubitemid 24184409)
17. Stein MD, Solomon DA, Herman DS, Anderson BJ, Miller I. Depression severity and drug injection HIV risk behaviors. Am J Psychiatry. 2003;160(9):1659-1662. (Pubitemid 41079553)
18. Gossop M, Green L, Phillips G, Bradley B. Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study. Br J Psychiatry. 1989;154:348-353. (Pubitemid 19091811)
19. Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58(5):503-508. (Pubitemid 32411332)
20. Hser YI, Huang D, Chou CP, Anglin MD. Trajectories of heroin addiction: growth mixture modeling results based on a 33-year follow-up study. Eval Rev. 2007;31(6):548-563.
21. Nurco DN, Cisin IH, Balter MB. Addict careers. II. The first ten years. Int J Addict. 1981;16(8):1327-1356. (Pubitemid 12165592)
22. Nurco DN, Cisin IH, Balter MB. Addict careers. III. Trends across time. Int J Addict. 1981;16(8):1357-1372. (Pubitemid 12165593)
23. Shah NG, Galai N, Celentano DD, Vlahov D, Strathdee SA. Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000. Drug Alcohol Depend. 2006;83(2):147-156. (Pubitemid 44208952)
24. Mäkelä K. Studies of the reliability and validity of the Addiction Severity Index. Addiction. 2004;99(4): 398-410, discussion 1-8. (Pubitemid 38499707)
25. Reinert DF, Allen JP. The Alcohol Use Disorders Identification Test (AUDIT): a review of recent research. Alcohol Clin Exp Res. 2002;26(2):272-279. (Pubitemid 34157764)
26. Song JY, Safaeian M, Strathdee SA, Vlahov D, Celentano DD. The prevalence of homelessness among injection drug users with and without HIV infection. J Urban Health. 2000;77(4):678-687. (Pubitemid 32059235)
27. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162(3):199-200. (Pubitemid 41373523)
28. Steensma C, Boivin JF, Blais L, Roy E. Cessation of injecting drug use among street-based youth. J Urban Health. 2005;82(4):622-637. (Pubitemid 41758609)
29. Corsi KF, Kwiatkowski CF, Booth RE. Treatment entry and predictors among opiate-using injection drug users. Am J Drug Alcohol Abuse. 2007;33(1):121-127. (Pubitemid 46423551)
30. Evans JL, Hahn JA, Lum PJ, Stein ES, Page K. Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study). Drug Alcohol Depend. 2009;101(3):152-157.
31. Anglin MD, Almog IJ, Fisher DG, Peters KR. Alcohol use by heroin addicts: evidence for an inverse relationship. A study of methadone maintenance and drug-free treatment samples. Am J Drug Alcohol Abuse. 1989;15 (2):191-207. (Pubitemid 19139801)
32. Shoptaw S, Rotheram-Fuller E, Yang X, et al. Smoking cessation in methadone maintenance. Addiction (Abingdon, England). 2002;97(10):1317-1328, discussion 25.
33. Deren S, Beardsley M, Coyle S, Singer M. HIV serostatus and risk behaviors in a multisite sample of drug users. J Psychoactive Drugs. 1998;30(3):239-245. (Pubitemid 28467629)
34. Macalino GE, Ko H, Celentano DD, et al. Drug use patterns over time among HIV-seropositive and HIVseronegative women: the HER study experience. J Acquir Immune Defic Syndr. 2003;33(4):500-505. (Pubitemid 36886079)
35. Fleming CA, Christiansen D, Nunes D, et al. Healthrelated quality of life of patients with HIV disease: impact of hepatitis C coinfection. Clin Infect Dis. 2004;38 (4):572-578. (Pubitemid 38250969)
36. Scott CK. A replicable model for achieving over 90% follow-up rates in longitudinal studies of substance abusers. Drug Alcohol Depend. 2004;74(1):21-36. (Pubitemid 38457050)
37. Friedmann PD, Lemon SC, Anderson BJ, Stein MD. Predictors of follow-up health status in the Drug Abuse Treatment Outcome Study (DATOS). Drug Alcohol Depend. 2003;69(3):243-251. (Pubitemid 36293936)
38. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989;320(9):545-550. (Pubitemid 19070537)
39. Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000;284(4):450-456. (Pubitemid 30484478)
40. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51(3):253-263, discussion 67-68.
41. Bouhnik AD, Chesney M, Carrieri P, et al. Nonadherence among HIV-infected injecting drug users: the impact of social instability. J Acquir Immune Defic Syndr. 2002;31(suppl 3):S149-S153. (Pubitemid 35453577)
42. Edlin BR. Prevention and treatment of hepatitis C in injection drug users. Hepatology. 2002;36(5 suppl 1): S210-S219. (Pubitemid 35253483)
43. Stein MD, Anderson BJ. Nicotine and drug interaction expectancies among methadone maintained cigarette smokers. J Subst Abuse Treat. 2003;24(4):357-361. (Pubitemid 36809289)